Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.36 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11119746 | 1.00 | TDP1 (0.47) | TDP1L3MBTL1KCNH2DHFRHSD11B1 | |
| SCHEMBL4607711 | 1.00 | TDP1 (0.47) | TDP1L3MBTL1KCNH2DHFRHSD11B1 | |
| SCHEMBL29908366 | 1.00 | TDP1 (0.47) | TDP1L3MBTL1KCNH2DHFRHSD11B1 | |
| SCHEMBL29791423 | 1.00 | TDP1 (0.47) | TDP1L3MBTL1KCNH2DHFRHSD11B1 | |
| SCHEMBL28673468 | 1.00 | TDP1 (0.47) | TDP1L3MBTL1KCNH2DHFRHSD11B1 | |
| Water SCHEMBL3623340 | 0.98 | TDP1 (0.46) | TDP1L3MBTL1KCNH2DHFRHSD11B1 | |
| SCHEMBL15639197 | 0.98 | TDP1 (0.49) | TDP1L3MBTL1KCNH2DHFRHSD11B1 | |
| SCHEMBL9544351 | 0.93 | L3MBTL1 (0.42) | TDP1L3MBTL1KDM4ELMNANPC1 | |
| SCHEMBL10246570 | 0.85 | PDE4A (0.39) | L3MBTL1KDM4E | |
| SCHEMBL11629358 | 0.84 | HSD11B1 (0.44) | TDP1L3MBTL1KCNH2HSD11B1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 577 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618090-B2 | Method for increasing the extraction rate of chondroitin sulfate prepared from tilapia skull | GUANGDONG OCEAN UNIVERSITY (CN) | 2026-05-05 | — | — | US | claimed |
| US-12324850-B2 | Compositions and methods for cleaning, decontamination and treating subjects exposed to chemical irritants | REFLEX RED STORM, LLC. (US) | 2025-06-10 | — | — | US | claimed |
| CN-120078026-A | Use of alkylpyridinium salts for controlling plant parasitic nematodes | 兰州大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119031839-A | Compositions comprising an antimicrobial agent and an alkyl ketal ester compound | 西姆莱斯股份公司 | 2024-11-26 | — | — | CN | claimed |
| US-20240247293-A1 | METHOD FOR INCREASING THE EXTRACTION RATE OF CHONDROITIN SULFATE PREPARED FROM TILAPIA SKULL | GUANGDONG OCEAN UNIVERSITY (CN) | 2024-07-25 | — | — | US | claimed |
| CN-118005521-A | Synthesis method of benzocaine | 陕西科技大学 | 2024-05-10 | — | — | CN | claimed |
| CN-118005501-A | Method for preparing mandelic acid | 陕西科技大学 | 2024-05-10 | — | — | CN | claimed |
| CN-117603679-A | Preparation method of ratio type fluorescent probe and application of ratio type fluorescent probe in detection of cetyl pyridine bromide | 河南师范大学 | 2024-02-27 | — | — | CN | claimed |
| CN-117531489-A | Polymer-loaded modified black talc composite adsorbent and preparation method and application thereof | 浙江工业大学 | 2024-02-09 | — | — | CN | claimed |
| WO-2024022108-A1 | ORAL CARE CLEANING SHEET, AND PREPARATION METHOD AND USE METHOD THEREFOR | 广州洁生日化有限公司 | 2024-02-01 | — | — | WO | claimed |
| WO-2002027827-A1 | TUNGSTEN-CONTAINING FUEL CELL CATALYST AND METHOD OF MAKING SAME | OSRAM SYLVANIA, INC. (US) | 2002-04-04 | — | — | WO | claimed |
| EP-0711546-B1 | OPHTHALMIC SOLUTION BASED ON DICLOFENAC AND TOBRAMYCINE AND ITS APPLICATIONS | ALCON CUSI S A (ES) | 2001-01-03 | — | — | EP | claimed |
| EP-0592348-B1 | Pharmaceutical formulation comprised of polymyxin-trimethoprim and an anti-inflammatory drug for ophthalmic and optic topical use | CUSI LAB (ES) | 1998-01-07 | — | — | EP | claimed |
| US-5679665-A | Pharmaceutical formulation comprised of polymyxintrimethoprim and an anti-inflammatory drug for ophthalmic and otic topical use | LABORATORIOS CUSI, S.A. (ES) | 1997-10-21 | — | — | US | claimed |
| EP-0711546-A1 | OPHTALMIC SOLUTION BASED ON DICLOFENAC AND TOBRAMICINE AND ITS APPLICATIONS | LABORATORIOS CUSI, S.A. (ES) | 1996-05-15 | — | — | EP | claimed |
| EP-0661055-A1 | Pharmaceutical formulation containing clobetasone and tobramycin and applications thereof | LABORATORIOS CUSI, S.A. (ES) | 1995-07-05 | — | — | EP | claimed |
| EP-0592348-A1 | Pharmaceutical formulation comprised of polymyxin-trimethoprim and an anti-inflammatory drug for ophthalmic and optic topical use | LABORATORIOS CUSI, S.A. (ES) | 1994-04-13 | — | — | EP | claimed |
| EP-0012926-B1 | SOLUTIONS OF X-RAY CONTRAST AGENTS | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1984-03-07 | — | — | EP | claimed |
| WO-1980001244-A1 | X-RAY CONTRAST MEDIA SOLUTIONS | BYKGULDEN LOMBERG CHEM FAB (DE) | 1980-06-26 | — | — | WO | claimed |
| US-3960724-A | BROWN COAL | NOVEX TALALMANYFEJLESZTO ES ERTEKESITO KULKERESKEDELMI RT. (HU) | 1976-06-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618090-B2 | Method for increasing the extraction rate of chondroitin sulfate prepared from tilapia skull | MMP2, MMP13, MMP14 | TDP1 1056/4885L3MBTL1 4613/4885KCNH2 3528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.